OBJECTIVES: This study aims to assess the existence of a correlation between the applicability of end-of-life treatment criteria and the likelihood of NICE requiring a Patient Access Scheme (PAS) to recommend the treatment for funding. METHODS: A review of all patient access schemes in existence as of March 2014 for NICE-recommended drugs was conducted to assess how many of those were for medicines which met the end-of-life treatment criteria and whether the supplementary criteria for end-of-life treatments had any bearing on the final NICE recommendation. RESULTS: In total